Latus Bio

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Affinia Therapeutics

This company develops rationally designed gene therapies and viral vectors for patients with heart and central nervous system diseases.

Armatus

The company develops vectorized RNAi therapeutics to treat genetic neurological and neuromuscular diseases for patients with rare conditions.

Coave Therapeutics

The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.

ViaNautis

ViaNautis develops polymer-based nanovesicles to deliver genetic medicines across biological barriers for patients with central nervous system and respiratory diseases.

Neurogene Inc

This company develops genetic medicines and gene therapies to treat patients and families affected by rare neurological diseases including Rett syndrome and Batten disease.

Lysogene

Lysogene develops gene therapies to treat rare central nervous system diseases in paediatric patients.

Asklepios BioPharmaceutical

This clinical-stage company develops and manufactures adeno-associated virus gene therapies for patients with rare genetic, neuromuscular, central nervous system and cardiovascular disorders.